JD HEALTH (06618) to surpass market expectations in performance for 2024, with total annual revenue reaching 58.2 billion yuan.

On March 6, JD HEALTH Limited (stock code "JD HEALTH", stock codes: 06618 [HKD counter] and 86618 [RMB counter]) released its annual performance announcement for 2024. In 2024, JD HEALTH's total revenue reached 58.2 billion RMB, and its net profit under Non-IFRS standards reached 4.79 billion RMB, exceeding market expectations. As of December 31, 2024, JD HEALTH had over 183 million active users in the past 12 months; the number of third-party partner merchants exceeded 100,000, and the platform ecosystem continued to improve. The daily average online consultation volume of JD Health's Internet hospital has exceeded 490,000. As a leading new type of medical and health service enterprise, JD HEALTH has always adhered to the strategic positioning of "core supply chain of pharmaceutical and health products, medical services as the focus, and digital-driven comprehensive and scenario-based health management enterprise." actively responded to national policies and regulatory guidance, and continuously built an integrated service system. SEC Commissioner of JD Group and CEO of JD HEALTH, Jin Enlin, stated, "In 2024, JD HEALTH has made several innovative breakthroughs in the fields of health product retail and medical health services, with the continuous amplification of social and industry value effects. We will actively fulfill corporate social responsibility, strive to create sustainable value for shareholders and society, and achieve long-term high-quality development." Strengthening pharmaceutical and health supply chain capabilities, comprehensive and deep layout of all-channel business In 2024, JD HEALTH continued to strengthen its advantages in self-operation, enhance the competitiveness of online platforms and instant retail businesses, achieve complementary advantages of three business models, and further open up the ecosystem to achieve high-quality growth with industry chain partners. In 2024, JD HEALTH continued to expand its advantage in self-operation, deepen cooperation with pharmaceutical companies and health product suppliers, continuously improve supply chain efficiency, provide users with a richer range of products and better services, and maintain its leading position in core categories of drugs. In terms of drug retail, based on the continuous enrichment of drug supply, JD HEALTH has assisted in brand innovation and digital upgrades, promoting industry transformation and high-quality development. During this process, JD HEALTH continues to consolidate its advantage as the "first station for new special drugs on the entire network." Through mature initial public offering solutions, help pharmaceutical companies accelerate the full-channel expansion of new drugs and provide patients with cutting-edge treatment options synchronized with the global. In the field of nutrition and health, JD HEALTH deepened cooperation with brand partners, actively expanded segmented category markets, and achieved mutual growth with partners. At the same time, JD HEALTH also published category standard systems for "JD Good Nutrition" and "JD Good Nutrition," actively accelerating the standardization and regularization of the entire category of nutritional health industry. In terms of category breakthroughs, JD HEALTH continues to strengthen the advantages of household medical equipment appliances represented by smart monitoring and respiratory oxygenation, and uses the elderly care scene as a breakthrough to further consolidate its leading position in the industry. In 2024, JD HEALTH served as the venue for the age-old consumer coupons in 19 regions such as Sichuan Province, Guangdong Province, and Henan Province, fully meeting the diverse health needs of the elderly. In the past year, JD HEALTH has increased support for platform merchants, strengthened the synergistic effect between online platform business and self-operated business, and improved the health consumption experience of users. As of December 31, 2024, the number of third-party merchants exceeded 100,000, and the platform ecosystem continued to improve. In 2024, JD HEALTH further strengthened its instant retail business, accelerating the innovation layout of all-channel businesses. As of December 31, 2024, "JD Buy Medicine and Send in Seconds" has successively opened "Online Purchase of Medicine and Medical Insurance Individual Account Payment" services in 18 cities such as Shanghai, Beijing, Guangzhou, Shenzhen, Foshan, Chengdu, Zhengzhou, Shenyang, and Tianjin, and connected to more than 3,000 national medical insurance designated pharmacies, covering more than 100 million people. In addition, JD HEALTH has opened several new types of Jingdong pharmacies in Beijing, creating a new offline pharmacy consumption and service experience; and launched the first self-service drug sales and pick-up machine in Haidian District, Beijing, to more efficiently meet the local residents' medication needs. Connecting the service loop of "Medicine + Inspection + Diagnosis + Medicine," accelerating the integration of Wuxi Online Offline Communication Information Technology Co., Ltd. service formats In 2024, JD HEALTH persisted in focusing on user health, promoting innovation in medical and health service models, further perfecting the internet medical service loop, upgrading the experience of at-home services, and meeting users' multi-level health needs. As of December 31, 2024, the daily average online consultation volume of the JD Internet Hospital exceeded 490,000. Over the past year, the JD Internet Hospital continued to consolidate its advantages in internet medical services, leading the industry, and achieving a service loop of "Medicine + Inspection + Diagnosis + Medicine." From online consultation with doctors and doorstep sample collection testing, to doctor diagnosis and prescription and medication delivery to home, the complete process of seeing a doctor and buying medicine can be efficiently completed in the service format centered around the JD Internet Hospital. At the same time, JD HEALTH continued to strengthen the construction of internet medical specialty capabilities. In the field of mental health specialties, JD HEALTH initiated the project of "Automatic Assisted Medical Record Generation System based on multi-modal large model AI technology" with Wuhan University People's Hospital, to improve the efficiency and accuracy of outpatient services in psychiatry through technological innovation. JD HEALTH also cooperated with Shanghai Mental Health Center, Peking University Sixth Hospital, Xiangya Hospital of Central South University, and Wuhan Mental Health Center and other leading domestic institutions in mental health specialties, to jointly begin a.Launch a series of popular science education projects to accelerate the public's deep understanding of digital mental health services. In the field of dermatology, JD HEALTH has invited over 120 doctors and experts and more than 6000 patients to carry out a skin AI patient management project, jointly exploring the innovative applications of large-scale model technology in assisting diagnosis, customizing diagnosis and treatment plans, post-diagnosis follow-up, etc. Currently, the large-scale application of AI in dermatology has been implemented, with an accuracy rate of over 95% in AI multimodal diagnosis.JD HEALTH is actively expanding the number of projects and geographical coverage of the "JD Daojia Quick Testing" service, launching 149 home testing service products for users in 12 cities, providing users with offline medical institution-level testing and inspection services. In the past year, the "JD Nurse at Home" service has also launched nearly 40 home medical care projects, where users can order services online and have licensed nurses provide professional medical care services such as blood collection, wound dressing, and injections at their homes. Promoting the large-scale application of medical models and landing in all scenarios to help medical inclusion with technology By 2024, JD HEALTH will further accelerate the application of large-scale model technology in various service scenarios, aiming to provide users with a more professional, convenient, and safe integrated medical health service experience. As of now, JD HEALTH is the first internet medical platform to scale up and land large-scale model applications in the industry, dedicated to making patients' medical visits more comfortable, doctors' clinical research more efficient, and hospitals' overall operations easier. Over the past year, JD HEALTH has released smart health assistants such as "Kangkang," AI mental health companion products like "Chatting Universe," mobile blood pressure testing services, and more, aiming to build an online medical service ecosystem entrance. For medical professionals, JD HEALTH has created the "Smart Doctor Assistant," providing functions such as clinical decision support, intelligent patient management, and clinical research assistance, which has become the most widely used and adopted intelligent diagnosis tool by doctors. In hospital settings, JD HEALTH has upgraded the intelligentization of the hospital's outpatient process to bring a more convenient experience to patients seeking medical care; among them, the new generation smart hospital service product jointly built by JD HEALTH and the First Affiliated Hospital of Wenzhou Medical University has begun to be widely promoted and implemented. Fully leveraging its own advantages and actively taking on corporate social responsibility By 2024, JD HEALTH will fully leverage its supply chain, medical services, and other advantages to steadily advance the operation of rare diseases, medical social work public welfare projects, and initiate innovative public welfare projects such as children's mental health and expired drug recycling. The "JD HEALTH Rare Disease Care Plan" has been launched for three years, providing assistance to 637 patients, with funds and material value exceeding 6 million RMB. The "Yi Xin Yi Zhan" medical social work public welfare project initiated by JD HEALTH, in cooperation with the Peking Union Medical College Hospital Rare Diseases Outpatient Clinic, Peking University First Hospital Neurology Department, and Children's Medical Center, has provided medical support to more than 20,000 patients. JD HEALTH has also initiated the "Expired Drug Recycling Public Welfare Project," with over 57,000 users participating nationwide, collecting a total weight of 11 tons of medications, generating a wide-ranging social impact. The "Growing Hearts and Minds" children's mental health protection campaign initiated by JD HEALTH has introduced professional mental health services into primary and secondary schools, establishing cooperation with multiple schools in Beijing, Xinjiang, Jilin, and benefiting nearly ten thousand teachers and students. In the future, JD HEALTH will continue to consolidate its advantages in retail pharmacies, fully leverage its self-operated and online platforms, as well as synergize its eco-system between offline and online channels, continuously strengthen its leading position in the industry's comprehensive, all-channel pharmaceutical health supply chain system, further build trust with brands and merchant partners, improve the accessibility and user experience of pharmaceutical and health products across all channels, and maintain the leading market share in core categories such as medications. JD HEALTH will also continue to drive innovation in medical health service models, aiming to connect more medical health service institutions and a wider range of resources such as doctors, pharmacists, nutritionists, etc., continually improve the integrated medical health service system. JD HEALTH is also committed to applying digital and intelligent means to a wider range of users, doctors, and partners, driving the accelerated implementation of inclusive healthcare through technological innovation. JD HEALTH will always adhere to the operating philosophy of "worthy of trust, with the user's health at the center of value creation," closely cooperating with ecosystem partners to jointly improve the integrated new medical health service ecosystem and promote development with consumers, industry, partners, society, and the environment.